Products for Research Use Only
RegisterLogin

Quavonlimab

CAT: 0804-HY-P99809-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99809-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Quavonlimab (MK-1308) is a novel anti-CTLA-4 antibody[1].
CAS Number
2254059-25-9
Product Name Alternative
MK-1308
UNSPSC
12352203
Target
CTLA-4
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/quavonlimab.html
Purity
99.0
Solubility
10 mM in DMSO
Smiles
[Quavonlimab]
Molecular Weight
(144.24 kDa)
References & Citations
[1]Perets R, et al. Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer. Ann Oncol. 2021;32 (3) :395-403.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
MBS5822982Quavonlimab
GTR18333802-01Quavonlimab Antibody
WA3401Research Grade Quavonlimab
E55B0906Quavonlimab (Reference antibody)
A138522Quavonlimab Biosimilar (Monoclonal, IgG1)
21-955Quavonlimab - Research Grade Biosimilar
ICH5794-20mgQuavonlimab Biosimilar - Research Grade
GTR18696571-01Quavonlimab Human Monoclonal Antibody
GTR18780307-01(Quavonlimab) Biosimilar Reference Antibody
C00747-1mgQuavonlimab (Anti-CTLA-4 / CD152)

Popular Products